These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16950806

  • 1. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.
    Cantero G, Campanella C, Mateos S, Cortés F.
    Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II.
    Cantero G, Pastor N, Mateos S, Campanella C, Cortés F.
    Mutat Res; 2006 Jul 25; 599(1-2):160-6. PubMed ID: 16574165
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Toward a comprehensive model for induced endoreduplication.
    Cortés F, Mateos S, Pastor N, Domínguez I.
    Life Sci; 2004 Nov 26; 76(2):121-35. PubMed ID: 15519359
    [Abstract] [Full Text] [Related]

  • 8. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells.
    Mateos S, Domínguez I, Pastor N, Cantero G, Cortés F.
    Mutat Res; 2005 Oct 15; 578(1-2):33-42. PubMed ID: 16202795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
    Hasinoff BB, Wu X, Begleiter A, Guziec LJ, Guziec F, Giorgianni A, Yang S, Jiang Y, Yalowich JC.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(2):221-33. PubMed ID: 16010589
    [Abstract] [Full Text] [Related]

  • 11. The free radical scavenging activity of four flavonoids determined by the comet assay.
    Horvathova K, Novotny L, Vachalkova A.
    Neoplasma; 2003 Jan 15; 50(4):291-5. PubMed ID: 12937843
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
    López-Lázaro M, Willmore E, Austin CA.
    Mutat Res; 2010 Feb 15; 696(1):41-7. PubMed ID: 20025993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
    Bridewell DJ, Finlay GJ, Baguley BC.
    Anticancer Drug Des; 2001 Dec 15; 16(6):317-24. PubMed ID: 12375884
    [Abstract] [Full Text] [Related]

  • 19. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
    Constantinou AI, Husband A.
    Anticancer Res; 2002 Dec 15; 22(5):2581-5. PubMed ID: 12529967
    [Abstract] [Full Text] [Related]

  • 20. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor.
    Hajji N, Mateos S, Pastor N, Domínguez I, Cortés F.
    Mutat Res; 2005 May 02; 583(1):26-35. PubMed ID: 15866463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.